ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025
Dec. 22, 2025 — ProPhase Labs, Inc. (NASDAQ: PRPH) is hitting one of the most consequential “inflection points” a micro-cap stock can face: a Nasdaq compliance deadline, a reverse stock split that reshapes how the ticker trades, and a newly announced non-binding reverse merger proposal that could dramatically change what ProPhase Labs is going forward. Reuters+3NASDAQ Trader+3ProPhase Labs, Inc.+3 In plain English: PRPH investors are watching two parallel storylines unfold at once—(1) staying listed and (2) potentially being “re-made” via a reverse merger with Europe-based Advanced Biological Laboratories S.A. (ABL). ProPhase Labs, Inc.+2Euronext Live+2 Why ProPhase Labs stock is in